# Chai Discovery Raises $400 Million for AI Molecular Design Platform

> financing · REPORTED · 2026-07-01

Chai Discovery raised $400 million to scale its AI-driven molecular design platform, which is designed to support drug discovery across multiple targets and molecule types and has secured relationships with major pharmaceutical companies. The round signals strong investor appetite for reusable AI infrastructure in drug development.

About Chai Discovery: Chai Discovery is an AI drug discovery company that builds foundation models for molecular design, enabling pharmaceutical partners to identify and optimize therapeutic candidates across diverse disease targets and modality types.

- Company: Chai Discovery
- Sector: biotech
- Primary source: https://www.lqventures.com/healthcare-ai-and-digital-health-strategic-roundup-july-3-august-2-2026/

---
Source: MedFuel Intel news monitor. Verification tier: REPORTED. Informational only, not investment advice. Corrections: media@medfuelinc.com.